Status:
COMPLETED
ADAMTS13 in Thrombotic Thrombocytopenic Purpura
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Thrombotic Thrombocytopenic Purpura
Eligibility:
All Genders
Brief Summary
Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy defined by the spontaneous formation of platelet thrombi in the microvessels. These platelet microthrombi are responsible for ...
Detailed Description
Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy defined by the spontaneous formation of platelet thrombi in the microvessels. These platelet microthrombi are responsible for ...
Eligibility Criteria
Inclusion
- clinical suspicion of TTP
- Hemoglobin level \< 10 g/dl (adult) or \< 12 g/dl (child)
- Platelet level \< 150 giga/l
- ADAMTS13 activity \< 5%
Exclusion
- Cancer
- Organ graft
- HIV infection
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT00426686
Start Date
November 1 2006
End Date
April 1 2011
Last Update
December 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Antoine Béclère
Clamart, France, 92140